Search results
Intercept (ICPT) Earnings and Sales Miss Estimates in Q2
Zacks via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. ICPT incurred a loss of 68 cents per share in second-quarter 2022,...
Intercept (ICPT) Q3 Earnings Miss, Sales Beat, View Raised
Zacks via Yahoo Finance· 2 years agoShares of Intercept Pharmaceuticals, Inc. ICPT rose 13.4% on Nov 1 after the company beat sales...
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
Investor's Business Daily· 1 year agoThe Food and Drug Administration will likely reject Intercept Pharmaceuticals' highly watched liver...
Intercept (ICPT) Q4 Earnings Beat, Ocaliva Sales Increase
Zacks via Yahoo Finance· 1 year agoShares of Intercept Pharmaceuticals, Inc. ICPT rose 3.89% on Mar 2 after the company reported...
Does Intercept (ICPT) Have the Potential to Rally 52.08% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 52.1% in...
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals reached a settlement with Amneal Pharmaceuticals that delays a generic...
Intercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Y
Zacks via Yahoo Finance· 11 months agoIntercept (ICPT) reports a lower net loss and beats on revenues in the second quarter. The company...
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoIntercept (ICPT) delivered earnings and revenue surprises of -28.30% and 24.34%, respectively, for...
Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Zacks via Yahoo Finance· 1 year agoIntercept (ICPT) doesn't possess the right combination of the two key ingredients for a likely...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) down to US$672m market cap, but institutional owners...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Intercept Pharmaceuticals implies that they have...